1. Stocks
    2. /
  2. Volpara Health Technologies (ASX: VHT)
    3. /

Volpara Health Technologies (ASX: VHT) Share Price and News

Price

 

Movement

   

  (20 mins delayed)

52 Week Range

  -  

 
1 Year Return

 

Volpara Health Technologies Chart and Price Data

Fundamentals Data provided by Morningstar.

Share Price

Day Change

52 Week Range

-

Yesterday's Close

Today's Open

Days Range

-

Volume

Avg. Volume (1 month)

Turnover

as at 24 Feb 3:44pm

    • Volpara Health Technologies (ASX: VHT)
    Latest News

    Dollar sign made from grass growing from ground as one person drips water on it and another holds coin
    Growth Shares

    2 ASX shares I think are great long-term buys

    | Tristan Harrison

    These two ASX shares have strong outlooks this decade. Here's why...

    Read more »

    ASX bank shares buy A young boy in a business suit giving thumbs up with piggy banks and coin piles
    Share Market News

    Could now be a great time to start investing in ASX shares?

    | Tristan Harrison

    Is it a good time to start investing in ASX shares? There has been a lot of volatility in 2022.

    Read more »

    A doctor sits with a patient and uses a pen to point to certain parts of her mammogram scan
    Earnings Results

    Volpara share price up on record full-year results

    | Zach Bristow

    ASX investors appear to be pleased with Volpara's results.

    Read more »

    A woman faces the camera with her lip raised up to the side in total confusion.
    Growth Shares

    2 ASX-listed companies that are growing rapidly

    | Tristan Harrison

    These two ASX shares have dropped heavily, yet as companies they continue to grow.

    Read more »

    A young woman sits at her desk in deep contemplation with her hand to her chin while seriously considering information she is reading on her laptop
    Growth Shares

    Buy these 2 impressive ASX shares in May 2022: experts

    | Tristan Harrison

    These two ASX shares are both growing and could be impressive investments, according to experts.

    Read more »

    Two plants grow in jars filled with coins.
    Growth Shares

    2 rapidly growing ASX shares that are on sale: experts

    | Tristan Harrison

    These two ASX shares could be at bargain prices despite their continuing growth.

    Read more »

    A medical researcher rests his forehead on his fist with a dejected look on his face while sitting behind a scientific microscope with another researcher's hand on his shoulder as if giving comfort.
    Healthcare Shares

    Volpara share price slips despite milestone CEO change

    | Aaron Teboneras

    Volpara shares have come under pressure despite the company's management update.

    Read more »

    ASX shares upgrade buy Woman in glasses writing on buy on board
    Growth Shares

    2 great ASX shares to buy in April: experts

    | Tristan Harrison

    Temple & Webster is one ASX share rated as an opportunity.

    Read more »

    a biomedical researcher sits at his desk with his hand on his chin, thinking and giving a small smile with a microscope next to him and an array of test tubes and beackers behind him on shelves in a well-lit bright office.
    Healthcare Shares

    Do ASX biotech shares offer 'good buying' after the sell-off? Experts weigh in

    | Bernd Struben

    After some strong support in early 2021, biotechnology stocks took a beating over the past 6 months.

    Read more »

    a happy investor with a wide smile points to a graph that shows an upward trending share price
    Growth Shares

    2 ASX growth shares to buy this month: experts

    | Tristan Harrison

    Temple & Webster is one of the leading ASX growth shares that are rated as a buy.

    Read more »

    A man in a white coat holds a laptop in one hand and his head in the other, it's bad news.
    Broker Notes

    Down 33% in 2022, is this ASX healthcare share a buy following the company's latest trial result?

    | Zach Bristow

    What can be said about Volpara's prospects in 2022?

    Read more »

    A female scientist sits at her desk looking stressed out while working in an AnteoTech lab.
    Healthcare Shares

    4 ASX healthcare shares at 52-week lows

    | Tristan Harrison

    A number of ASX healthcare shares just hit 52-week lows.

    Read more »

    Frequently Asked Questions

    No, the ASX healthcare share has not yet paid any dividends.

    Volpara listed on 27 April 2016.

    VHT ASX Announcements

    An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.

    DateAnnouncementPrice Sensitive?TimeNo. of PagesFile Size
    YesNo

    About Volpara Health Technologies

    Volpara Health Technologies Ltd (ASX: VHT) is a small but growing research, development, and manufacturing company that provides breast screening technology and risk analysis for patients and medical professionals.

    Volpara’s artificial intelligence-powered software for early detection of breast cancer is used by more than 2,000 facilities and more than 5,600 mammography technologists, impacting nearly 15 million patients globally. Volpara is based in Wellington, New Zealand, and also has a US office in Seattle.

    Volpara Health Technologies Ltd (ASX: VHT) was removed from the ASX Official List on 22 May 2024.

    Directors & Management Data provided by Morningstar.

    Data provided by Morningstar.
    Name Title Start Date Profile
    Ms Teri Thomas Chief Executive OfficerManaging Director Apr 2022
    Teri joined the Board in October 2022. She has a
    long history of executive management in healthcare
    IT ranging from strategy and operations to running
    global sales and marketing teams. This includes a
    20-year career at Epic, a global leader in electronic
    health record (EHR) systems and other software
    solutions used by hospitals and healthcare
    organisations in the United States and internationally
    Mr Craig Hadfield Chief Financial OfficerJoint Company Secretary Mar 2017
    -
    Mr Fred Struve General CounselJoint Company Secretary Oct 2022
    -
    Craig Hadfield Chief Financial OfficerJoint Company Secretary
    -
    Fred Struve General CounselJoint Company Secretary
    -

    Top Shareholders Data provided by Morningstar.

    Data provided by Morningstar.
    Name Shares Capital
    No Top 20 27,534,688 10.84%
    Patagorang Pty Ltd 18,467,848 7.27%
    Ralph Highnam And Kyc Trustees 106 Limited <Highnam Share A/C> 16,213,561 6.38%
    Citicorp Nominees Pty Limited 11,830,450 4.66%
    HSBC Custody Nominees (Australia) Limited 8,187,911 3.22%
    Custodial Services Limited <Beneficiaries Holding A/C> 8,154,911 3.21%
    Bnp Paribas Noms (Nz) Ltd <Drp> 7,061,556 2.78%
    Prof Sir Michael Brady 6,619,075 2.61%
    Mr Marcus Sarner 5,980,404 2.35%
    National Nominees Limited 4,728,818 1.86%
    BNP Paribas Nominees Pty Ltd <Ib Au Noms Retailclient 4,420,193 1.74%
    Sir Martin Francis Wood 3,004,655 1.18%
    Lady Kathleen Audrey Wood 3,004,654 1.18%
    BNP Paribas Noms Pty Ltd <Drp> 2,527,511 0.99%
    Prof Martin Yaffe 1,966,483 0.77%
    Mr John Anthony Dell 1,928,864 0.76%
    BNP Paribas Nominees Pty Ltd HUB24 Custodial Serv Limited 1,917,409 0.75%
    Prof Nico Karssemeijer 1,806,806 0.71%
    Melbourne Securities Corporation Limited <Horizon 3 Biotech Fund A/C> 1,519,964 0.60%
    RX HOUSE TRUST PTY LTD 880,758 0.35%

    Profile

    since

    Note